Biotech - Press Releases

Date	Title	Company
16-Nov-2020	Eiger Announces Case Studies Demonstrating Regression of Liver Fibrosis Following 48 Weeks of Therapy with Peginterferon Lambda in Patients with Chronic Hepatitis Delta Virus (HDV) Infection Presented at The Liver Meeting Digital Experience(TM) 2020	Eiger BioPharmaceuticals, Inc.
16-Nov-2020	Kodiak Sciences Announces Proposed Offering of Common Stock	Kodiak Sciences Inc.
16-Nov-2020	SynDevRx Announces Positive Data from Phase 1 Safety Trial of SDX-7320 in Late Stage Cancer Patients	SynDevRx
16-Nov-2020	AMZELL to initiate FDA-approved Phase 3 trial of innovative injectable treatment for infantile epileptic disease	AMZELL B.V
16-Nov-2020	Q BioMed’s Uttroside-B Receives U.S. Patent in Treatment of Liver Cancer	Q BioMed Inc
16-Nov-2020	OncoZenge secures approximately SEK 70 million in financing ahead of spin-off and separate listing	Moberg Pharma
16-Nov-2020	EITAN GROUP REBRANDS AS EITAN MEDICAL	Eitan Medical
16-Nov-2020	RedHill Biopharma Completes Enrollment for COVID-19 U.S. Phase 2 Study with Opaganib - Data Expected in the Coming Weeks	RedHill Biopharma Ltd.
16-Nov-2020	Envision Pharma Group acquires Two Labs to advance its position as a global strategic partner to pharma and create a unique and unrivaled launch excellence offering	Envision Pharma Group
16-Nov-2020	Myricx Pharma Launches with £4.5M Financing to Progress its Novel NMT inhibitors in Cancer	Myricx Pharma
16-Nov-2020	Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study	Moderna, Inc
16-Nov-2020	Bone Therapeutics announces completion of the acquisition of its cell therapy manufacturing subsidiary SCTS by Catalent	Bone Therapeutics
16-Nov-2020	Calypso Biotech Announces Successful Dosing of First Phase 1 Cohort with Anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 for the Treatment of Autoimmune Diseases	Calypso Biotech
16-Nov-2020	FDA issues Complete Response Letter for sutimlimab, an investigational treatment for hemolysis in adults with cold agglutinin disease	Sanofi
16-Nov-2020	Farxiga showed cardiovascular and renal benefit in patients with chronic kidney disease irrespective of cardiovascular disease status	AstraZeneca
16-Nov-2020	Full results from AFFIRM-AHF study show Ferinject® significantly reduces hospitalizations after acute heart failure in patients with iron deficiency	Vifor Pharma
16-Nov-2020	Kodiak Sciences Completes Enrollment of DAZZLE Phase 2b/3 Pivotal Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration	Kodiak Sciences Inc.
16-Nov-2020	Cytiva supports Clover Biopharmaceuticals to scale up the output of its vaccine candidate	Cytiva
16-Nov-2020	Cytiva supports Clover Biopharmaceuticals to scale up the output of its vaccine candidate	Cytiva
16-Nov-2020	Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology	Innovent Biologics, Inc.